OptiNose Gross Profit

The latest gross profit for OPTN is $74M as of March 2025. That compares with $66M in the prior-year period — up 12.9% year over year. That is below the Healthcare sector average of $67B. Investors often review this figure alongside OptiNose's historical trend and sector peers before judging valuation or financial health.

Over the past year, OPTN's gross profit moved from $66M to $74M — a 12.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in OptiNose's operating scale or balance-sheet position.

Against Healthcare companies, OPTN currently prints $74M for gross profit, while the sector average sits near $67B. That is roughly 99.9% below the sector mean. Large gaps often invite a closer look at OptiNose's growth, margins, and balance sheet.

A gross profit figure of $74M for OPTN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $67B. Explore the charts below for those layers of context.

After noting OPTN's gross profit ($74M), review year-over-year change from $66M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.